tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Future for NewAmsterdam Pharma: Buy Rating Backed by Strong Financials and Positive Trial Data
PremiumRatingsPromising Future for NewAmsterdam Pharma: Buy Rating Backed by Strong Financials and Positive Trial Data
2M ago
NewAmsterdam Pharma Reports Q2 2025 Financial Results
Premium
Company Announcements
NewAmsterdam Pharma Reports Q2 2025 Financial Results
2M ago
Promising Developments and Strong Financial Position Support Buy Rating for NewAmsterdam Pharma
Premium
Ratings
Promising Developments and Strong Financial Position Support Buy Rating for NewAmsterdam Pharma
2M ago
Promising Alzheimer’s Biomarker Data and Expert Enthusiasm Drive Buy Rating for NewAmsterdam Pharma
PremiumRatingsPromising Alzheimer’s Biomarker Data and Expert Enthusiasm Drive Buy Rating for NewAmsterdam Pharma
2M ago
NewAmsterdam Pharma’s Promising Phase 3 Alzheimer’s Trial Results
Premium
Company Announcements
NewAmsterdam Pharma’s Promising Phase 3 Alzheimer’s Trial Results
2M ago
NewAmsterdam Pharma presents data from BROADWAY trial at AAIC
Premium
The Fly
NewAmsterdam Pharma presents data from BROADWAY trial at AAIC
2M ago
Strong Buy Recommendation for NewAmsterdam Pharma Driven by Promising Cardiovascular and Alzheimer’s Opportunities
PremiumRatingsStrong Buy Recommendation for NewAmsterdam Pharma Driven by Promising Cardiovascular and Alzheimer’s Opportunities
4M ago
NewAmsterdam Pharma Schedules R&D Day for June 2025
Premium
Company Announcements
NewAmsterdam Pharma Schedules R&D Day for June 2025
4M ago
NewAmsterdam Pharma initiated with a Buy at Stifel
Premium
The Fly
NewAmsterdam Pharma initiated with a Buy at Stifel
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100